VytronUS Lands $31,600,000 Series B Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5c793732-475e-48dc-bfae-c940922b72f1 - Date
10/30/2014 - Company Name
VytronUS - Mailing Address
658 N. Pastoria Ave. Sunnyvale, CA 94085 USA - Company Description
The company operates as a medical device developer. - Website
http://www.vytronus.com - Transaction Type
Venture Equity - Transaction Amount
$31,600,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds will be used for development and validation of VytronUS’s proprietary Low-Intensity Collimated Ultrasound (LICU) Cardiac Imaging and Ablation System to treat atrial fibrillation and other arrhythmias in forthcoming clinical trials. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
